Page last updated: 2024-11-03

ro 31-8220 and Lung Neoplasms

ro 31-8220 has been researched along with Lung Neoplasms in 3 studies

Ro 31-8220: a protein kinase C inhibitor

Lung Neoplasms: Tumors or cancer of the LUNG.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hemström, TH1
Sandström, M1
Zhivotovsky, B1
Aggarwal, S1
Kim, SW1
Ryu, SH1
Chung, WC1
Koo, JS1
Courage, C1
Bradder, SM1
Jones, T1
Schultze-Mosgau, MH1
Gescher, A1

Other Studies

3 other studies available for ro 31-8220 and Lung Neoplasms

ArticleYear
Inhibitors of the PI3-kinase/Akt pathway induce mitotic catastrophe in non-small cell lung cancer cells.
    International journal of cancer, 2006, Sep-01, Volume: 119, Issue:5

    Topics: Androstadienes; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell S

2006
Growth suppression of lung cancer cells by targeting cyclic AMP response element-binding protein.
    Cancer research, 2008, Feb-15, Volume: 68, Issue:4

    Topics: Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Growth Processes; Cell Line, Tumor; C

2008
Characterisation of novel human lung carcinoma cell lines selected for resistance to anti-neoplastic analogues of staurosporine.
    International journal of cancer, 1997, Nov-27, Volume: 73, Issue:5

    Topics: Adenocarcinoma; Alkaloids; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cass

1997